National Institute for Clinical Excellence guidance: too NICE to glycoprotein IIb/IIIa inhibitors?

被引：3

作者：

Knight, CJ

机构：

[1] London Chest Hosp, London E2 9JX, England

[2] King George Hosp, London E2 9JX, England

来源：

HEART | 2001年 / 85卷 / 05期

关键词：

D O I：

10.1136/heart.85.5.481

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：481 / 483

页数：3

共 22 条

[1]

[Anonymous], 1994, Circulation, V89, P1545

[2]

Bazzino O, 1998, NEW ENGL J MED, V338, P1488

[3] Management of acute coronary syndromes:: acute coronary syndromes without persistent ST segment elevation -: Recommendations of the Task Force of the European Society of Cardiology [J].

Bertrand, ME ;

Simoons, ML ;

Fox, KAA ;

Wallentin, LC ;

Hamm, CW ;

McFadden, E ;

De Feyter, PJ ;

Specchia, G ;

Ruzyllo, W .

EUROPEAN HEART JOURNAL, 2000, 21 (17) :1406-1432

[4] Current role of platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes [J].

Bhatt, DL ;

Topol, EJ .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 284 (12) :1549-1558

[5] Outcomes in patients with acute non-Q-wave myocardial infarction randomly assigned to an invasive as compared with a conservative management strategy [J].

Boden, WE ;

O'Rourke, RA ;

Crawford, MH ;

Blaustein, AS ;

Deedwania, PC ;

Zoble, RG ;

Wexler, LF ;

Kleiger, RE ;

Pepine, CJ ;

Ferry, DR ;

Chow, BK ;

Lavori, PW .

NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (25) :1785-1792

[6] Platelet glycoprotein IIb/IIIa receptor inhibition in non-ST-elevation acute coronary syndromes -: Early benefit during medical treatment only, with additional protection during percutaneous coronary intervention [J].

Boersma, E ;

Akkerhuis, KM ;

Théroux, P ;

Califf, RM ;

Topol, EJ ;

Simoons, ML .

CIRCULATION, 1999, 100 (20) :2045-2048

[7] USE OF A MONOCLONAL-ANTIBODY DIRECTED AGAINST THE PLATELET GLYCOPROTEIN IIB/IIIA RECEPTOR IN HIGH-RISK CORONARY ANGIOPLASTY [J].

CALIFF, RM ;

SHADOFF, N ;

VALETT, N ;

BATES, E ;

GALEANA, A ;

KNOPF, W ;

SHAFTEL, J ;

BENDER, MJ ;

AVERSANO, T ;

RAQUENO, J ;

GURBEL, P ;

COWFER, J ;

COHEN, M ;

CROSS, P ;

BITTL, J ;

EDDINGS, K ;

TAYLOR, M ;

DEROSA, K ;

HATTEL, L ;

COOPER, L ;

ESHELMAN, B ;

FINTEL, D ;

NIEMYSKI, P ;

KLEIN, L ;

KENNEDY, H ;

THORNTON, T ;

KEREIAKES, D ;

MARTIN, L ;

ANDERSON, L ;

HIGBY, N ;

ELLIS, S ;

BREZINA, K ;

GEORGE, B ;

CHAPEKIS, A ;

SMITH, D ;

ANWAR, A ;

GERBER, TL ;

PRITCHARD, GL ;

MYLER, R ;

SHAW, R ;

MURPHY, M ;

WARD, K ;

MADIGAN, NP ;

BLANKENSHIP, J ;

HALBERT, M ;

FLANAGAN, C ;

TANNENBAUM, M ;

POLICH, M ;

STEVENSON, C ;

TCHENG, J .

NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (14) :956-961

[8] Invasive versus conservative strategies in unstable angina and non-Q-wave myocardial infarction following treatment with tirofiban:: Rationale and study design of the international TACTICS-TIMI 18 trial [J].

Cannon, CP ;

Weintraub, WS ;

Demopoulos, LA ;

Robertson, DH ;

Gormley, GJ ;

Braunwald, E .

AMERICAN JOURNAL OF CARDIOLOGY, 1998, 82 (06) :731-736

[9] Clinical outcomes, risk stratification and practice patterns of unstable angina and myocardial infarction without ST elevation: Prospective Registry of Acute Ischaemic Syndromes in the UK (PRAIS-UK) [J].

Collinson, J ;

Flather, MD ;

Fox, KAA ;

Findlay, I ;

Rodrigues, E ;

Dooley, P ;

Ludman, P ;

Adgey, J ;

Bowker, TJ ;

Mattu, P .

EUROPEAN HEART JOURNAL, 2000, 21 (17) :1450-1457

[10] Coronary disease - The pathophysiology of acute coronary syndromes [J].

Davies, MJ .

HEART, 2000, 83 (03) :361-366

← 1 2 3 →